Colgate-Palmolive reported a consolidated net profit of Rs 379.82 crore for the March quarter (Q4FY24), a growth of 20.11% from the year-ago period. This was ahead of street estimates which forecast net profit at Rs 360 crore for the period.
Revenue rose 10.35% year-on-year (y-o-y) to Rs 1,480.66 crore, rising 10.35% in the year-ago quarter, marginally ahead of street estimates of Rs 1,468 crore for the period.
Earnings before interest, tax, depreciation and amortization (Ebitda) for the quarter stood at Rs 532 crore, growing nearly 18% versus the year-ago period.
Bloomberg consensus estimates had pegged Ebitda at Rs 504 crore. Ebitda margins improved by 220 basis points (bps) y-o-y to 35.7%.
The Board announced a second interim dividend of Rs 26 per share, along with a special one-time interim dividend of Rs 10 per share, it said.
“We have continued to invest in superior, science-backed oral care formulations, upgrading the product and packaging quality of our core portfolio,” said Prabha Narasimhan, MD and CEO, Colgate-Palmolive India.
Rural sales outpaced urban, and products were performing well in modern trade and e-commerce, she said.
Shares of Colgate-Palmolive ended 1.44% lower at Rs 2,818.40 apiece on the BSE ahead of the company’s earnings on Tuesday.
